MAPT and Alzheimer disease: The fact that, in ADs, no evidence of associations were seen between atrophy rate and white matter pathology, Aβ, or tau, may reflect the fact that this population is more likely to have underlying AD pathology and is therefore more homogeneous (Jellinger, 2006), reducing power to detect associations.